Marken expands nursing services offered globally

By Vassia Barba contact

- Last updated on GMT

(Image: Getty/Drazen Zigic)
(Image: Getty/Drazen Zigic)

Related tags: Marken, Logistics, trial recruitment, Patient centricity

Marken's home care and nursing services for home-based clinical trials are now operational across all of its global logistics network.

The company’s plan to build a global network of local home care providers was announced​ in 2018 and the first patients were treated by Marken’s care providers in the beginning of 2019.

The service is now active globally and fully integrated throughout Marken’s suite of services, according to Marken. The home health care service includes drug administration, biological sample collection, patient assessment, and exams, which traditionally would be conducted at the site.  

As part of its direct-to-patient logistics services, Marken’s home health care and nursing services is expected to improve patient recruitment and retention by facilitating decentralized, home-based clinical trials.

“The service will expand the global reach and capabilities for patient enrolment into trials by fully supporting virtual trials with at-home study drug administration and increasing recruitment opportunities,”​ Kimberly Finn, vice president of Marken’s Global Patient Centric Services told us.

According to Finn, the company has also established global standard operating procedures to oversee the nursing providers.

Marken stated that the service is in compliance with applicable regulations, including HIPAA and GDPR. Additionally, the company has adopted a new operating software in order to reduce paper-based study visit documentation

Related news

Show more

Related products

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

Lessons Learned: Clinical Trials During a Pandemic

Lessons Learned: Clinical Trials During a Pandemic

PCM TRIALS | 01-Sep-2020 | Technical / White Paper

In a recent survey of clinical trial professionals (including pharmaceutical sponsors, CROs, site representatives and vendors), respondents reported that...

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Manufacturing Cyto and Non-Cyto Drugs in One Facility

Baxter BioPharma Solutions | 01-Mar-2020 | Technical / White Paper

Recent market reports suggest increasing product niches, which may lead to decreasing numbers of units per product, making dedicated facilities less practical....

Related suppliers

Follow us


View more